利伐沙班医保后多少钱？

Rivaroxaban is a new type of oral anticoagulant drug currently on the market. It is convenient during application and has little interaction with food and other drugs. It has a wide therapeutic window and does not require monitoring of coagulation function. It has certain advantages during application. During the application process, the drug can play a certain role at key sites in the coagulation pathway. It has a good anticoagulant effect, can combine with the active site of factor Xa, and is reversible. Therefore, after the drug is applied, there will rarely be adverse bleeding phenomena, which will help speed up the recovery of patients and improve the current status of thrombosis treatment.

So far, rivaroxaban has been marketed in the United States, the European Union, China and other countries and regions, bringing new opportunities and options for the treatment of patients everywhere. For domestic patients, not only can they buy the rivaroxaban they need in major domestic hospitals, but they can also enjoy the benefits brought by medical insurance. So, how much does rivaroxaban cost after medical insurance?

Since there are certain differences in medical insurance policies across the country, please consult the relevant local departments and personnel for the reimbursement ratio and final selling price of Rivaroxaban. In addition, patients can also choose to purchase drugs overseas. By purchasing drugs through this method, patients can also reduce a certain financial burden.

According to Medical Partner Travel, rivaroxaban produced by Bayer in Germany mainly comes in two specifications: one is rivaroxaban with a specification of 20mg*28 tablets/box, which sells for about $400; the other is 15mg*28 tablets/box of rivaroxaban, which sells for less than 400$. Patients who need this drug can selectively purchase the drug based on their own economic situation. Patients should note when using rivaroxaban: Patients who are allergic to any excipients in the tablets, have lesions or conditions with a significant risk of major bleeding, and patients with clinically significant active bleeding should use this drug with caution or stop using it to avoid adverse events.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: